# Effect of Magnesium Sulfate Infusion Rate on Magnesium Retention in Critically Ill Patients

> **NCT01426165** · NA · TERMINATED · sponsor: **CAMC Health System** · enrollment: 5 (actual)

## Conditions studied

- Primary Hypomagnesemia (Disorder)

## Interventions

- **DRUG:** Magnesium Sulfate

## Key facts

- **NCT ID:** NCT01426165
- **Lead sponsor:** CAMC Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-04
- **Primary completion:** 2012-04
- **Final completion:** 2012-12
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Issues with recruitment. PI decided to terminate study
- **Last updated:** 2014-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426165, "Effect of Magnesium Sulfate Infusion Rate on Magnesium Retention in Critically Ill Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01426165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*